Cargando…

Association Between Systemic Inflammation and Incident Diabetes in HIV-Infected Patients After Initiation of Antiretroviral Therapy

OBJECTIVE: To determine whether systemic inflammation after initiation of HIV-antiretroviral therapy (ART) is associated with the development of diabetes. RESEARCH DESIGN AND METHODS: We conducted a nested case-control study, comparing 55 previously ART-naive individuals who developed diabetes 48 we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Todd T., Tassiopoulos, Katherine, Bosch, Ronald J., Shikuma, Cecilia, McComsey, Grace A.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945167/ https://www.ncbi.nlm.nih.gov/pubmed/20664016 http://dx.doi.org/10.2337/dc10-0633

Ejemplares similares

Association Between Weight Gain and the Incidence of Cardiometabolic Conditions Among People Living with HIV-1 at High Risk of Weight Gain Initiated on Antiretroviral Therapy
por: McComsey, Grace A., et al.
Publicado: (2022)

Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States
por: McComsey, Grace A., et al.
Publicado: (2021)

Changes in Waist Circumference in HIV-Infected Individuals Initiating a Raltegravir or Protease Inhibitor Regimen: Effects of Sex and Race
por: Bhagwat, Priya, et al.
Publicado: (2018)

Changes in the Fungal Marker β-D-Glucan After Antiretroviral Therapy and Association With Adiposity
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2019)

Comprehensive assessment of neurocognitive function, inflammation markers, and adiposity in treated HIV and control
por: Mouchati, Christian, et al.
Publicado: (2022)

933. Serum Albumin Is Associated With Higher Inflammation and Carotid Atherosclerosis in Treated HIV Infection
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2018)

Cystatin C-Based Renal Function Changes After Antiretroviral Initiation: A Substudy of a Randomized Trial
por: Gupta, Samir K., et al.
Publicado: (2014)

Rosuvastatin Decreases Intestinal Fatty Acid Binding Protein (I-FABP), but Does Not Alter Zonulin or Lipopolysaccharide Binding Protein (LBP) Levels, in HIV-Infected Subjects on Antiretroviral Therapy
por: Funderburg, Nicholas T., et al.
Publicado: (2016)

Risks associated with antiretroviral treatment for human immunodeficiency virus (HIV): qualitative analysis of social media data and health state utility valuation
por: Matza, Louis S., et al.
Publicado: (2017)

2528. Inflammation and Plasma Selenium and Chromium in Ugandan Children Living with HIV
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2019)

HIV and race are independently associated with endothelial dysfunction
por: Mouchati, Christian, et al.
Publicado: (2023)

1570. Exploring Antiretroviral Therapy (ART) Switch Decisions in Clinical Setting: Trio Health Mixed Methods Study
por: Elion, Rick A, et al.
Publicado: (2023)

Coronary artery calcium, HIV and inflammation in Uganda compared with the USA
por: Alencherry, Ben, et al.
Publicado: (2019)

Metabolic complications and treatment of perinatally HIV-infected children and adolescents
por: Barlow-Mosha, Linda, et al.
Publicado: (2013)

Association of Anisocytosis with Markers of Immune Activation and Exhaustion in Treated HIV
por: Al-Kindi, Sadeer G., et al.
Publicado: (2017)

Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2016)

Effects of Antiretroviral Therapy on Autonomic Function in Early HIV Infection: A Preliminary Report
por: Chow, Dominic, et al.
Publicado: (2012)

Incidence of Diabetes Mellitus and Obesity and the Overlap of Comorbidities in HIV+ Hispanics Initiating Antiretroviral Therapy
por: Gomes, Angelina, et al.
Publicado: (2016)

Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients
por: Bedimo, Roger, et al.
Publicado: (2016)

Dysbiosis in the oral bacterial and fungal microbiome of HIV-infected subjects is associated with clinical and immunologic variables of HIV infection
por: Mukherjee, Pranab K., et al.
Publicado: (2018)

Vitamin D Supplementation Does Not Affect Metabolic Changes Seen With ART Initiation
por: Muhammad, Josh, et al.
Publicado: (2017)

Cannabis Use Is Associated With Decreased Antiretroviral Therapy Adherence Among Older Adults With HIV
por: Manuzak, Jennifer A, et al.
Publicado: (2023)

Serum Albumin Is Associated With Higher Inflammation and Carotid Atherosclerosis in Treated Human Immunodeficiency Virus Infection
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2018)

Potential impact on HIV incidence of higher HIV testing rates and earlier antiretroviral therapy initiation in MSM
por: Phillips, Andrew N., et al.
Publicado: (2015)

Characterization of Circulating Fibrocytes in People Living with HIV on Stable Antiretroviral Therapy
por: Dean, Logan S., et al.
Publicado: (2022)

Analysis of relationships between 25-hydroxyvitamin D, parathyroid hormone and cathelicidin with inflammation and cardiovascular risk in subjects with paediatric systemic lupus erythematosus: an Atherosclerosis Prevention in Paediatric Lupus Erythematosus (APPLE) study
por: Gupta, Varsha, et al.
Publicado: (2018)

1984. Effects of Semaglutide on Adipose Tissue in HIV-Associated Lipohypertrophy
por: McComsey, Grace A, et al.
Publicado: (2023)

1609 Plasma markers of immune activation likely reflect related but distinct processes of cellular immune activation in HIV-infected persons before and after suppression of viremia by antiretroviral therapy: ACTG 5260
por: Kelesidis, Theodoros, et al.
Publicado: (2014)

Sex, HIV Status, and Measures of Cardiac Stress and Fibrosis in Uganda
por: Kipke, Jasmine, et al.
Publicado: (2021)

Older Age Is Associated with Peripheral Blood Expansion of Naïve B Cells in HIV-Infected Subjects on Antiretroviral Therapy
por: Van Epps, Puja, et al.
Publicado: (2014)

Subclinical Atherosclerosis among HIV-Infected Adults Attending HIV/AIDS Care at Two Large Ambulatory HIV Clinics in Uganda
por: Ssinabulya, Isaac, et al.
Publicado: (2014)

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials
por: Sax, Paul E, et al.
Publicado: (2019)

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation
por: Gandhi, Rajesh T., et al.
Publicado: (2017)

HIV drug resistance among adults initiating antiretroviral therapy in Uganda
por: Watera, Christine, et al.
Publicado: (2021)

Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India
por: Alvarez-Uria, Gerardo, et al.
Publicado: (2014)

Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection
por: El Kamari, Vanessa, et al.
Publicado: (2021)

Impact of Heroin and HIV on Gut Integrity and Immune Activation
por: Hileman, Corrilynn O., et al.
Publicado: (2022)

Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity
por: Lake, Jordan E., et al.
Publicado: (2015)

Clinical Features and Outcomes of Coronavirus Disease 2019 Among People With Human Immunodeficiency Virus in the United States: A Multicenter Study From a Large Global Health Research Network (TriNetX)
por: Yendewa, George A, et al.
Publicado: (2021)

Rapid initiation of antiretroviral therapy for people living with HIV
por: Mateo‐Urdiales, Alberto, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qbp1r0qt3uohejh7hnp5a35ioh